ArticleslgStudy

biology

Von Hippel–Lindau disease

Von Hippel–Lindau disease is a biology topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Von Hippel–Lindau disease rather than just read about it. In short: Von Hippel–Lindau disease (VHL), also known as Von Hippel–Lindau syndrome, is a rare genetic disorder with multisystem involvement. It is characterized by polycystic disease and benign tumors with potential for subsequent malignant transformation.

Von Hippel–Lindau disease — main illustration
Von Hippel–Lindau disease — illustration

Key takeaways

  • Von Hippel–Lindau disease belongs to biology; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect Von Hippel–Lindau disease to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of Von Hippel–Lindau disease from memory before moving on to harder problems.

Reference excerpt

Von Hippel–Lindau disease (VHL), also known as Von Hippel–Lindau syndrome, is a rare genetic disorder with multisystem involvement. It is characterized by polycystic disease and benign tumors with potential for subsequent malignant transformation. It is a type of phakomatosis that results from a mutation in the Von Hippel–Lindau tumor suppressor gene on chromosome 3p25.3.

Signs and symptoms

Signs and symptoms associated with VHL disease include headaches, problems with balance and walking, dizziness, weakness of the limbs, vision problems, and high blood pressure. Six organ systems mainly are affected: the central nervous system; retina; pancreas; kidney; adrenal gland; epididymis. Conditions associated with VHL disease include angiomatosis, hemangioblastomas, pheochromocytoma, renal cell carcinoma, pancreatic cysts (pancreatic serous cystadenoma), endolymphatic sac tumor, and bilateral papillary cystadenomas of the epididymis (men) or broad ligament of the uterus (women). Angiomatosis occurs in 37.2% of patients presenting with VHL disease and usually occurs in the retina. As a result, loss of vision is very common. However, other organs can be affected: strokes, heart attacks, and cardiovascular disease are common additional symptoms. Approximately 40% of VHL disease presents with CNS hemangioblastomas and they are present in around 60–80%. Spinal hemangioblastomas are found in 13–59% of VHL disease and are specific because 80% are found in VHL disease. Although all of these tumors are common in VHL disease, around half of cases present with only one tumor type. Most people with VHL develop symptoms in their mid-twenties.

Pathogenesis The disease is caused by mutations of the Von Hippel–Lindau tumor suppressor (VHL) gene on the short arm of chromosome 3 (3p25-26). There are over 1500 germline mutations and somatic mutations found in VHL disease.

Every cell in the body has two copies of every gene (bar those found in the sex chromosomes, X and Y). In VHL disease, one copy of the VHL gene has a mutation and produces a faulty VHL protein (pVHL). However, the second copy still produces a functional protein. The condition is inherited in an autosomal dominant manner – one copy of the faulty gene is sufficient to increase the risk of developing tumours. Approximately 20% of cases of VHL disease are found in individuals without a family history, known as de novo mutations. An inherited mutation of the VHL gene is responsible for the remaining 80 percent of cases. Of mutations in the VHL gene, 30–40% consist of 50-250kb deletion mutations that remove either part of the gene or the whole gene and flanking regions of DNA. The remaining 60–70% of VHL disease is caused by the truncation of pVHL by nonsense mutations, indel mutations or splice site mutations.

VHL protein

The VHL protein (pVHL) is involved in the regulation of a protein known as hypoxia inducible factor 1α (HIF1α). This is a subunit of a heterodimeric transcription factor that at normal cellular oxygen levels is highly regulated. In normal physiological conditions, pVHL recognizes and binds to HIF1α only when oxygen is present due to the post translational hydroxylation of two proline residues within the HIF1α protein. pVHL is an E3 ligase that ubiquitinates HIF1α and causes its degradation by the proteasome. In low oxygen conditions or in cases of VHL disease where the VHL gene is mutated, pVHL does not bind to HIF1α. This allows the subunit to dimerise with HIF1β and activate the transcription of a number of genes, including vascular endothelial growth factor, platelet-derived growth factor B, erythropoietin and genes involved in glucose uptake and metabolism.

Diagnosis The detection of tumours specific to VHL disease is important in the disease's diagnosis. In individuals with a family history of VHL disease, one hemangioblastoma, pheochromocytoma or renal cell carcinoma may be sufficient to make a diagnosis. As all the tumours associated with VHL disease can be found sporadically, at least two tumours must be identified to diagnose VHL disease in a person without a family history. Genetic diagnosis is also useful in VHL disease diagnosis. In hereditary VHL disease, techniques such as the Southern blot and gene sequencing can be used to analyse DNA and identify mutations. These tests can be used to screen family members of those afflicted with VHL disease; de novo cases that produce genetic mosaicism are more difficult to detect because mutations are not found in the white blood cells that are used for genetic analysis.

Classification Von Hippel-Lindau (VHL) disease is classified into two main types based on the presence or absence of pheochromocytoma (pheo). VHL type 1 is characterized by the absence of pheo, while VHL type 2 encompasses individuals with pheo and is further divided into three subcategories: type 2A, type 2B, and type 2C. Diagnosis of VHL is guided by two key criteria. The first involves patients with a family history of developing hemangioblastomas (HB) in the central nervous system (CNS) or retinal angiomas (RA), pheo, pancreatic tumors or cysts, or epididymal cystadenomas. The second criterion applies to patients without a family history of VHL disease who present with hemangioblastomas or retinal angiomas in conjunction with other tumors such as renal cell carcinoma (RCC), pheo, pancreatic tumors or cysts, or epididymal cystadenomas.

Classification terms Pheo - A pheochromocytoma is an adrenal tumor that makes and releases excess catecholamines. These tumors can cause serious health problems including stroke, heart attack, and even death. Hemangioblastomas - a hemangioblastoma is a tumor that grows in the blood vessels of your brain, spinal cord or retina. It isn't cancerous, but it may grow and press on surrounding tissues. Usually, healthcare providers recommend removing a hemangioblastoma with surgery. After removal, a hemangioblastoma is unlikely to grow back. Retina angiomas - retinal capillary hemangiomas also known as retinal hemangioblastomas, occur most frequently in conjunction with von Hippel-Lindau (VHL) syndrome. These lesions are characterized by plump, but otherwise normal, retinal capillary endothelial cells with normal pericytes and basement membrane. Epidydimal cystadenomas- A cyst that grows on the male testes. Renal cell carcinoma- The most common type of kidney cancer.

… excerpt ends here. Continue reading the full article.

Illustrations

Von Hippel–Lindau disease illustration
Von Hippel–Lindau disease: Slit lamp photograph showing retinal detachment in Von Hippel–Lindau disease
Slit lamp photograph showing retinal detachment in Von Hippel–Lindau disease
Von Hippel–Lindau disease: Typical distribution of hemangioblastomas in Von Hippel–Lindau disease.
Typical distribution of hemangioblastomas in Von Hippel–Lindau disease.
Von Hippel–Lindau disease: Von Hippel–Lindau disease is inherited in an autosomal dominant pattern.
Von Hippel–Lindau disease is inherited in an autosomal dominant pattern.
Von Hippel–Lindau disease: The regulation of HIF1α by pVHL. Under normal oxygen levels, HIF1α binds pVHL through two hydroxylated proline residues and is polyubiquitinated by pVHL. This leads to its degradation via the proteasome. During hypoxia, the proline residues are not hydroxylated and pVHL cannot bind. HIF1α causes the transcription of genes that contain the hypoxia response element. In VHL disease, genetic mutations cause alterations to the pVHL protein, usually to the HIF1α binding site.
The regulation of HIF1α by pVHL. Under normal oxygen levels, HIF1α binds pVHL through two hydroxylated proline residues and is polyubiquitinated by pVHL. This leads to its degradation via the proteasome. During hypoxia, the proline residues are not hydroxylated and pVHL cannot bind. HIF1α causes the transcription of genes that contain the hypoxia response element. In VHL disease, genetic mutations cause alterations to the pVHL protein, usually to the HIF1α binding site.

Worked examples

Example 1 — a first encounter with Von Hippel–Lindau disease

Start with the simplest possible case. Write down what Von Hippel–Lindau disease claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In biology, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Von Hippel–Lindau disease before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Von Hippel–Lindau disease ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Von Hippel–Lindau disease

In research
Von Hippel–Lindau disease appears in biology research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses Von Hippel–Lindau disease in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
Von Hippel–Lindau disease is common in secondary-school and first-year university syllabi. It links to neighbouring topics Autosomal dominant disorders, Genodermatoses, Hereditary cancers, so understanding it makes those chapters shorter.
In everyday life
Look for Von Hippel–Lindau disease outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.
Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Von Hippel–Lindau disease” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Von Hippel–Lindau disease in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what Von Hippel–Lindau disease means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain Von Hippel–Lindau disease out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Von Hippel–Lindau disease in simple terms?

Von Hippel–Lindau disease (VHL), also known as Von Hippel–Lindau syndrome, is a rare genetic disorder with multisystem involvement. It is characterized by polycystic disease and benign tumors with potential for subsequent malignant transformation.

Why does Von Hippel–Lindau disease matter?

Because it connects several biology ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Von Hippel–Lindau disease?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Von Hippel–Lindau disease.

Tags

  • Autosomal dominant disorders
  • Genodermatoses
  • Hereditary cancers
  • Rare diseases
  • Syndromes

Keep exploring